Selected research
Market Outlook & Growth Opportunities
Global Cosmetic Peptide Synthesis Market Outlook and Growth Opportunities 2026
Market perspective
The global Cosmetic Peptide Synthesis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cosmetic Peptide Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cosmetic Peptide Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cosmetic Peptide Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cosmetic Peptide Synthesis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cosmetic Peptide Synthesis market include Activotec, Bio-Synthesis, Apeptide, CPC Scientific Inc., LifeTein, AmbioPharm, GL Biochem, AAPPTec and otwo biotech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cosmetic Peptide Synthesis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cosmetic Peptide Synthesis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cosmetic Peptide Synthesis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cosmetic Peptide Synthesis market.
Cosmetic Peptide Synthesis Segment by Company
Activotec
Bio-Synthesis
Apeptide
CPC Scientific Inc.
LifeTein
AmbioPharm
GL Biochem
AAPPTec
otwo biotech
Creative Peptides
RS Synthesis, LLC
Bio Basic Inc
GenScript
ProteoGenix
Bachem Inc.
Cosmetic Peptide Synthesis Segment by Type
Solid-Phase Peptide Synthesis
Liquid-Phase Peptide Synthesis
Others
Cosmetic Peptide Synthesis Segment by Application
Anti-aging
Eye Care
Anti-pigmentation
Hair Growth
Others
Cosmetic Peptide Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cosmetic Peptide Synthesis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cosmetic Peptide Synthesis key companies, revenue, market share, and recent developments.
3. To split the Cosmetic Peptide Synthesis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cosmetic Peptide Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cosmetic Peptide Synthesis significant trends, drivers, influence factors in global and regions.
6. To analyze Cosmetic Peptide Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic Peptide Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cosmetic Peptide Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic Peptide Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cosmetic Peptide Synthesis industry.
Chapter 3: Detailed analysis of Cosmetic Peptide Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cosmetic Peptide Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cosmetic Peptide Synthesis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Cosmetic Peptide Synthesis Industry Trends
Table 2. Cosmetic Peptide Synthesis Industry Drivers
Table 3. Cosmetic Peptide Synthesis Industry Opportunities and Challenges
Table 4. Cosmetic Peptide Synthesis Industry Restraints
Table 5. Global Cosmetic Peptide Synthesis Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Cosmetic Peptide Synthesis Revenue Share by Company (2021-2026)
Table 7. Global Cosmetic Peptide Synthesis Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Cosmetic Peptide Synthesis Key Company Manufacturing Base & Headquarters
Table 9. Global Cosmetic Peptide Synthesis Company, Product Type & Application
Table 10. Global Cosmetic Peptide Synthesis Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Cosmetic Peptide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Solid-Phase Peptide Synthesis
Table 15. Significant Companies of Liquid-Phase Peptide Synthesis
Table 16. Significant Companies of Others
Table 17. Global Cosmetic Peptide Synthesis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Cosmetic Peptide Synthesis Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Cosmetic Peptide Synthesis Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Cosmetic Peptide Synthesis Sales Value Share by Type (2021-2026)
Table 21. Global Cosmetic Peptide Synthesis Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Anti-aging
Table 23. Significant Companies of Eye Care
Table 24. Significant Companies of Anti-pigmentation
Table 25. Significant Companies of Hair Growth
Table 26. Significant Companies of Others
Table 27. Global Cosmetic Peptide Synthesis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Cosmetic Peptide Synthesis Sales Value by Application (2021-2026) & (US$ Million)
Table 29. Global Cosmetic Peptide Synthesis Sales Value by Application (2027-2032) & (US$ Million)
Table 30. Global Cosmetic Peptide Synthesis Sales Value Share by Application (2021-2026)
Table 31. Global Cosmetic Peptide Synthesis Sales Value Share by Application (2027-2032)
Table 32. Global Cosmetic Peptide Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Cosmetic Peptide Synthesis Sales Value by Region (2021-2026) & (US$ Million)
Table 34. Global Cosmetic Peptide Synthesis Sales Value Share by Region (2021-2026)
Table 35. Global Cosmetic Peptide Synthesis Sales Value by Region (2027-2032) & (US$ Million)
Table 36. Global Cosmetic Peptide Synthesis Sales Value Share by Region (2027-2032)
Table 37. Global Cosmetic Peptide Synthesis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Cosmetic Peptide Synthesis Sales Value by Country (2021-2026) & (US$ Million)
Table 39. Global Cosmetic Peptide Synthesis Sales Value Market Share by Country (2021-2026)
Table 40. Global Cosmetic Peptide Synthesis Sales Value by Country (2027-2032) & (US$ Million)
Table 41. Global Cosmetic Peptide Synthesis Sales Value Market Share by Country (2027-2032)
Table 42. Activotec Company Information
Table 43. Activotec Business Overview
Table 44. Activotec Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 45. Activotec Cosmetic Peptide Synthesis Product Portfolio
Table 46. Activotec Recent Development
Table 47. Bio-Synthesis Company Information
Table 48. Bio-Synthesis Business Overview
Table 49. Bio-Synthesis Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Bio-Synthesis Cosmetic Peptide Synthesis Product Portfolio
Table 51. Bio-Synthesis Recent Development
Table 52. Apeptide Company Information
Table 53. Apeptide Business Overview
Table 54. Apeptide Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 55. Apeptide Cosmetic Peptide Synthesis Product Portfolio
Table 56. Apeptide Recent Development
Table 57. CPC Scientific Inc. Company Information
Table 58. CPC Scientific Inc. Business Overview
Table 59. CPC Scientific Inc. Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 60. CPC Scientific Inc. Cosmetic Peptide Synthesis Product Portfolio
Table 61. CPC Scientific Inc. Recent Development
Table 62. LifeTein Company Information
Table 63. LifeTein Business Overview
Table 64. LifeTein Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. LifeTein Cosmetic Peptide Synthesis Product Portfolio
Table 66. LifeTein Recent Development
Table 67. AmbioPharm Company Information
Table 68. AmbioPharm Business Overview
Table 69. AmbioPharm Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. AmbioPharm Cosmetic Peptide Synthesis Product Portfolio
Table 71. AmbioPharm Recent Development
Table 72. GL Biochem Company Information
Table 73. GL Biochem Business Overview
Table 74. GL Biochem Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. GL Biochem Cosmetic Peptide Synthesis Product Portfolio
Table 76. GL Biochem Recent Development
Table 77. AAPPTec Company Information
Table 78. AAPPTec Business Overview
Table 79. AAPPTec Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. AAPPTec Cosmetic Peptide Synthesis Product Portfolio
Table 81. AAPPTec Recent Development
Table 82. otwo biotech Company Information
Table 83. otwo biotech Business Overview
Table 84. otwo biotech Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. otwo biotech Cosmetic Peptide Synthesis Product Portfolio
Table 86. otwo biotech Recent Development
Table 87. Creative Peptides Company Information
Table 88. Creative Peptides Business Overview
Table 89. Creative Peptides Cosmetic Peptide Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. Creative Peptides Cosmetic Peptide Synthesis Product Portfolio
Table 91. Creative Peptides Recent Development
Table 92. RS Synthesis, LLC Company Information
Table 93. RS Synthesis, LLC Business Overview
Table 94. RS Synthesis, LLC Cosmetic Peptide Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 95. RS Synthesis, LLC Cosmetic Peptide Synthesis Product Portfolio
Table 96. RS Synthesis, LLC Recent Development
Table 97. Bio Basic Inc Company Information
Table 98. Bio Basic Inc Business Overview
Table 99. Bio Basic Inc Cosmetic Peptide Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 100. Bio Basic Inc Cosmetic Peptide Synthesis Product Portfolio
Table 101. Bio Basic Inc Recent Development
Table 102. GenScript Company Information
Table 103. GenScript Business Overview
Table 104. GenScript Cosmetic Peptide Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 105. GenScript Cosmetic Peptide Synthesis Product Portfolio
Table 106. GenScript Recent Development
Table 107. ProteoGenix Company Information
Table 108. ProteoGenix Business Overview
Table 109. ProteoGenix Cosmetic Peptide Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 110. ProteoGenix Cosmetic Peptide Synthesis Product Portfolio
Table 111. ProteoGenix Recent Development
Table 112. Bachem Inc. Company Information
Table 113. Bachem Inc. Business Overview
Table 114. Bachem Inc. Cosmetic Peptide Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 115. Bachem Inc. Cosmetic Peptide Synthesis Product Portfolio
Table 116. Bachem Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Authors List of This Report
Table 119. Secondary Sources
Table 120. Primary Sources
List of Figures
Figure 1. Cosmetic Peptide Synthesis Product Image
Figure 2. Global Cosmetic Peptide Synthesis Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Cosmetic Peptide Synthesis Market Size (2021-2032) & (US$ Million)
Figure 4. Global Cosmetic Peptide Synthesis Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Solid-Phase Peptide Synthesis Image
Figure 8. Liquid-Phase Peptide Synthesis Image
Figure 9. Others Image
Figure 10. Global Cosmetic Peptide Synthesis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Cosmetic Peptide Synthesis Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Cosmetic Peptide Synthesis Sales Value Share by Type (2021-2032)
Figure 13. Anti-aging Image
Figure 14. Eye Care Image
Figure 15. Anti-pigmentation Image
Figure 16. Hair Growth Image
Figure 17. Others Image
Figure 18. Global Cosmetic Peptide Synthesis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Cosmetic Peptide Synthesis Sales Value Share 2021 VS 2025 VS 2032
Figure 20. Global Cosmetic Peptide Synthesis Sales Value Share by Application (2021-2032)
Figure 21. Global Cosmetic Peptide Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 22. Global Cosmetic Peptide Synthesis Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 23. North America Cosmetic Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 24. North America Cosmetic Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Europe Cosmetic Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 26. Europe Cosmetic Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Asia-Pacific Cosmetic Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 28. Asia-Pacific Cosmetic Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 29. South America Cosmetic Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 30. South America Cosmetic Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Middle East & Africa Cosmetic Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 32. Middle East & Africa Cosmetic Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 33. USA Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. USA Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. USA Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Canada Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Canada Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Canada Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Mexico Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Mexico Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Mexico Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Germany Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Germany Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Germany Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. France Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. France Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. France Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. U.K. Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. U.K. Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. U.K. Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Italy Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Italy Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Italy Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Spain Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Spain Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Spain Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Russia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Russia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Russia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Netherlands Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Netherlands Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Netherlands Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Nordic Countries Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Nordic Countries Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. China Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. China Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. China Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Japan Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Japan Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Japan Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. South Korea Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. South Korea Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. South Korea Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. India Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. India Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. India Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Australia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Australia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Australia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Southeast Asia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Southeast Asia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Brazil Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Brazil Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Brazil Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Argentina Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Argentina Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Argentina Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Chile Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Chile Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Chile Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Colombia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Colombia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Colombia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Peru Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Peru Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Peru Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Saudi Arabia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Israel Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Israel Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Israel Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. UAE Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. UAE Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. UAE Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Turkey Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Turkey Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Turkey Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Iran Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Iran Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Iran Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Egypt Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Egypt Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Egypt Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Years Considered
Figure 118. Research Process
Figure 119. Key Executives Interviewed
Scope & coverage.
Types
- Solid-Phase Peptide Synthesis
- Liquid-Phase Peptide Synthesis
- Others
Applications
- Anti-aging
- Eye Care
- Anti-pigmentation
- Hair Growth
- Others
Companies covered
- Activotec
- Bio-Synthesis
- Apeptide
- CPC Scientific Inc.
- LifeTein
- AmbioPharm
- GL Biochem
- AAPPTec
- otwo biotech
- Creative Peptides
- RS Synthesis, LLC
- Bio Basic Inc
- GenScript
- ProteoGenix
- Bachem Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cosmetic Peptide Synthesis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cosmetic Peptide Synthesis Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cosmetic Peptide Synthesis Market Dynamics
- 2.1 Cosmetic Peptide Synthesis Industry Trends
- 2.2 Cosmetic Peptide Synthesis Industry Drivers
- 2.3 Cosmetic Peptide Synthesis Industry Opportunities and Challenges
- 2.4 Cosmetic Peptide Synthesis Industry Restraints
3 Cosmetic Peptide Synthesis Market by Company
- 3.1 Global Cosmetic Peptide Synthesis Company Revenue Ranking in 2025
- 3.2 Global Cosmetic Peptide Synthesis Revenue by Company (2021-2026)
- 3.3 Global Cosmetic Peptide Synthesis Company Ranking (2024-2026)
- 3.4 Global Cosmetic Peptide Synthesis Company Manufacturing Base and Headquarters
- 3.5 Global Cosmetic Peptide Synthesis Company Product Type and Application
- 3.6 Global Cosmetic Peptide Synthesis Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cosmetic Peptide Synthesis Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cosmetic Peptide Synthesis Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cosmetic Peptide Synthesis Market by Type
- 4.1 Cosmetic Peptide Synthesis Type Introduction
- 4.1.1 Solid-Phase Peptide Synthesis
- 4.1.2 Liquid-Phase Peptide Synthesis
- 4.1.3 Others
- 4.2 Global Cosmetic Peptide Synthesis Sales Value by Type
- 4.2.1 Global Cosmetic Peptide Synthesis Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cosmetic Peptide Synthesis Sales Value by Type (2021-2032)
- 4.2.3 Global Cosmetic Peptide Synthesis Sales Value Share by Type (2021-2032)
5 Cosmetic Peptide Synthesis Market by Application
- 5.1 Cosmetic Peptide Synthesis Application Introduction
- 5.1.1 Anti-aging
- 5.1.2 Eye Care
- 5.1.3 Anti-pigmentation
- 5.1.4 Hair Growth
- 5.1.5 Others
- 5.2 Global Cosmetic Peptide Synthesis Sales Value by Application
- 5.2.1 Global Cosmetic Peptide Synthesis Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cosmetic Peptide Synthesis Sales Value by Application (2021-2032)
- 5.2.3 Global Cosmetic Peptide Synthesis Sales Value Share by Application (2021-2032)
6 Cosmetic Peptide Synthesis Regional Value Analysis
- 6.1 Global Cosmetic Peptide Synthesis Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cosmetic Peptide Synthesis Sales Value by Region (2021-2032)
- 6.2.1 Global Cosmetic Peptide Synthesis Sales Value by Region: 2021-2026
- 6.2.2 Global Cosmetic Peptide Synthesis Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cosmetic Peptide Synthesis Sales Value (2021-2032)
- 6.3.2 North America Cosmetic Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cosmetic Peptide Synthesis Sales Value (2021-2032)
- 6.4.2 Europe Cosmetic Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cosmetic Peptide Synthesis Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cosmetic Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cosmetic Peptide Synthesis Sales Value (2021-2032)
- 6.6.2 South America Cosmetic Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cosmetic Peptide Synthesis Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cosmetic Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
7 Cosmetic Peptide Synthesis Country-level Value Analysis
- 7.1 Global Cosmetic Peptide Synthesis Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cosmetic Peptide Synthesis Sales Value by Country (2021-2032)
- 7.2.1 Global Cosmetic Peptide Synthesis Sales Value by Country (2021-2026)
- 7.2.2 Global Cosmetic Peptide Synthesis Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cosmetic Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cosmetic Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cosmetic Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Activotec
- 8.1.1 Activotec Company Information
- 8.1.2 Activotec Business Overview
- 8.1.3 Activotec Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.1.4 Activotec Cosmetic Peptide Synthesis Product Portfolio
- 8.1.5 Activotec Recent Developments
- 8.2 Bio-Synthesis
- 8.2.1 Bio-Synthesis Company Information
- 8.2.2 Bio-Synthesis Business Overview
- 8.2.3 Bio-Synthesis Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.2.4 Bio-Synthesis Cosmetic Peptide Synthesis Product Portfolio
- 8.2.5 Bio-Synthesis Recent Developments
- 8.3 Apeptide
- 8.3.1 Apeptide Company Information
- 8.3.2 Apeptide Business Overview
- 8.3.3 Apeptide Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.3.4 Apeptide Cosmetic Peptide Synthesis Product Portfolio
- 8.3.5 Apeptide Recent Developments
- 8.4 CPC Scientific Inc.
- 8.4.1 CPC Scientific Inc. Company Information
- 8.4.2 CPC Scientific Inc. Business Overview
- 8.4.3 CPC Scientific Inc. Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.4.4 CPC Scientific Inc. Cosmetic Peptide Synthesis Product Portfolio
- 8.4.5 CPC Scientific Inc. Recent Developments
- 8.5 LifeTein
- 8.5.1 LifeTein Company Information
- 8.5.2 LifeTein Business Overview
- 8.5.3 LifeTein Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.5.4 LifeTein Cosmetic Peptide Synthesis Product Portfolio
- 8.5.5 LifeTein Recent Developments
- 8.6 AmbioPharm
- 8.6.1 AmbioPharm Company Information
- 8.6.2 AmbioPharm Business Overview
- 8.6.3 AmbioPharm Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.6.4 AmbioPharm Cosmetic Peptide Synthesis Product Portfolio
- 8.6.5 AmbioPharm Recent Developments
- 8.7 GL Biochem
- 8.7.1 GL Biochem Company Information
- 8.7.2 GL Biochem Business Overview
- 8.7.3 GL Biochem Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.7.4 GL Biochem Cosmetic Peptide Synthesis Product Portfolio
- 8.7.5 GL Biochem Recent Developments
- 8.8 AAPPTec
- 8.8.1 AAPPTec Company Information
- 8.8.2 AAPPTec Business Overview
- 8.8.3 AAPPTec Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.8.4 AAPPTec Cosmetic Peptide Synthesis Product Portfolio
- 8.8.5 AAPPTec Recent Developments
- 8.9 otwo biotech
- 8.9.1 otwo biotech Company Information
- 8.9.2 otwo biotech Business Overview
- 8.9.3 otwo biotech Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.9.4 otwo biotech Cosmetic Peptide Synthesis Product Portfolio
- 8.9.5 otwo biotech Recent Developments
- 8.10 Creative Peptides
- 8.10.1 Creative Peptides Company Information
- 8.10.2 Creative Peptides Business Overview
- 8.10.3 Creative Peptides Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.10.4 Creative Peptides Cosmetic Peptide Synthesis Product Portfolio
- 8.10.5 Creative Peptides Recent Developments
- 8.11 RS Synthesis, LLC
- 8.11.1 RS Synthesis, LLC Company Information
- 8.11.2 RS Synthesis, LLC Business Overview
- 8.11.3 RS Synthesis, LLC Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.11.4 RS Synthesis, LLC Cosmetic Peptide Synthesis Product Portfolio
- 8.11.5 RS Synthesis, LLC Recent Developments
- 8.12 Bio Basic Inc
- 8.12.1 Bio Basic Inc Company Information
- 8.12.2 Bio Basic Inc Business Overview
- 8.12.3 Bio Basic Inc Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.12.4 Bio Basic Inc Cosmetic Peptide Synthesis Product Portfolio
- 8.12.5 Bio Basic Inc Recent Developments
- 8.13 GenScript
- 8.13.1 GenScript Company Information
- 8.13.2 GenScript Business Overview
- 8.13.3 GenScript Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.13.4 GenScript Cosmetic Peptide Synthesis Product Portfolio
- 8.13.5 GenScript Recent Developments
- 8.14 ProteoGenix
- 8.14.1 ProteoGenix Company Information
- 8.14.2 ProteoGenix Business Overview
- 8.14.3 ProteoGenix Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.14.4 ProteoGenix Cosmetic Peptide Synthesis Product Portfolio
- 8.14.5 ProteoGenix Recent Developments
- 8.15 Bachem Inc.
- 8.15.1 Bachem Inc. Company Information
- 8.15.2 Bachem Inc. Business Overview
- 8.15.3 Bachem Inc. Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
- 8.15.4 Bachem Inc. Cosmetic Peptide Synthesis Product Portfolio
- 8.15.5 Bachem Inc. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst